Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game | Jeff Bauter Engel | 01/22/16 | Boston |
From Ambitions To Markets: Richard Kitney And More Synthetic Bio Views | Alex Lash | 01/06/16 | National |
UC Entrusts $250M To New Fund For Investment in Campus Startups | Bernadette Tansey | 12/16/15 | San Francisco |
West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags | Alex Lash | 12/04/15 | San Francisco |
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests | Ben Fidler | 11/11/15 | Boston |
Vertex, CRISPR Tx Team up on Gene Editing Drugs in $105M Pact | Ben Fidler | 10/26/15 | Boston |
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed | Stewart Lyman | 10/07/15 | National |
FlexTech Alliance To Manage $75M Defense Institute for Tech Manufacturing | Bernadette Tansey | 08/28/15 | San Francisco |
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More | Alex Lash | 07/06/15 | Seattle |
Bay Area Fund, Aligned With UC, Raises New To Cash To Seed Biotechs | Alex Lash | 05/12/15 | San Francisco |
Precision BioSciences Lands $26M for Gene-Editing Technology | Frank Vinluan | 05/11/15 | Raleigh Durham |
West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More | Alex Lash | 04/16/15 | San Francisco |
From Iceland to White House, Precision Medicine’s Promises & Hurdles | Alex Lash | 03/31/15 | National |
In New Gene-Editing World, Doudna Applies Both Brake and Gas Pedal | Alex Lash | 03/27/15 | San Francisco |
His Attacker Found Guilty, UCSD’s Steve Dowdy “Not Looking Back” | Alex Lash | 03/20/15 | San Diego |
Madison Vaccines Expands Series A To Advance Prostate Cancer Drugs | Jeff Bauter Engel | 03/10/15 | Wisconsin |
Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? | Alex Lash | 02/17/15 | National |
As Promised, LTI Pulls In Big Series A to Advance Parkinson’s Drug | Alex Lash | 02/03/15 | Boston |
Portfolium Reinvents the Resumé, Rolls Out App for Job Seekers | Bruce V. Bigelow | 01/28/15 | San Diego |
Speaking LINGO, Biogen R&D Chief Wants to Push Nerve Repair Boundary | Alex Lash | 01/26/15 | Boston |
Phononic Raises a Cool $44.5M for Refrigerator Technology | Frank Vinluan | 12/17/14 | Raleigh Durham |
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight | Alex Lash | 12/16/14 | National |
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda | Alex Lash | 12/02/14 | San Francisco |
Analysis: After a Boom-and-Bust Era, More Modest Growth at Polaris | Curt Woodward | 12/01/14 | Boston |
Bay Area Innovators To Shake Up “Biotech’s Epicenter” Event 12/17 | Alex Lash | 11/20/14 | San Francisco |
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More | Alex Lash | 11/20/14 | Seattle |
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray | Alex Lash | 11/18/14 | Boston |
What Early Looks From ASH Tell Us About Cancer Immunotherapy | Alex Lash | 11/07/14 | National |
UCSF Chancellor Hawgood Kicks Off “Biotech’s Epicenter” Forum 12/17 | Alex Lash | 10/28/14 | San Francisco |
University of California Incubators Eager to Scout Startups, Co-Investors for UC Ventures | Bernadette Tansey | 10/06/14 | San Francisco |